Introduction
Citalopram (CIT), paroxetine (PAR), and sertraline (SER) (Figure 1 ) are new antidepressants belonging to the class of the selective serotonin reuptake inhibitors (SSRIs). They exhibit clin- Reproduction (photocopying) of editorial content of this journal is prohibited without publisher's permission.
ical efficacy comparable to that of classical tricyclic antidepres sants, but they are devoid of some of the adverse anticholinergic and cardiovascular effects commonly associated with these drugs (1). In the organism, these SSRIs are biotransformed toNdemethylated metabolites (2) . Desmethylparoxetine is consid ered pharmacologically inactive, whereas desmethylcitalopram (DCIT), and perhaps also desmethylsertraline (DSER), contribute to the pharmacological activity of their parent drug (2) .
Although no therapeutic windows have been defined for SSRIs in contrast to tricyclic antidepressants, analytical methods for therapeutic drug monitoring of SSRIs are useful in several instances. They are necessary for pharmacokinetic experiments, but one of their major potential uses is to check compliance. It has been shown that up to one-third of patients stop taking their antidepressants after six weeks, two-thirds of whom do not report it to their general practitioner (3) . Several thin-layer chromatography, high-performance liquid chro matography (HPLC), or gas chromatography (GC) methods have been published (4) for the determination of the five SSRIs presently on the market (CIT, PAR, SER, fluoxetine [FLX] , fluvoxamine [FLV] ) and their metabolites in plasma or serum samples. Recently, we described a GC-mass spectrometric (GC-MS) method which allows the simultaneous determina tion of the enantiomers of FLV and either FLX or norfluoxetine (NFLX) after derivatization with (S)-(-)N-trifluoroacetylprolyl chloride (5). To our knowledge, this is the only published method which allows the simultaneous determination of two SSRIs (5) . Such methods would not only decrease the cost and speed up analysis, but would also be useful when two SSRIs are administered simultaneously (4) . In the present paper, we describe a sensitive and specific GC-MS method which simultaneously measures CIT, SER, PAR, and their N-demethylated pharmacologically active metabolites.
Experimental

Reagents
CIT hydrobromide, DCIT hydrochloride, and didesmethylci talopram (DDCIT) L-tartrate monohydrate were supplied by Lundbeck (Copenhagen, Denmark). SER hydrochloride and N-DSER maleate were obtained from Pfizer (Groton, CT). PAR hydrochloride was provided by SmithKline Beecham (Wor thing, United Kingdom). N-MMP was supplied by Novartis (Basel, Switzerland). N-Methyl-bis(trifluoroacetamide) was from Fluka (Buchs, Switzerland). Stock solutions of CIT, DCIT, and DDCIT were prepared using 10 ng/μL of each drug in 0.1M HC1, and stock solutions of PAR, SER, and DSER were pre pared using 100 ng/μL of each drug in 0.1M HC1. Working solutions were prepared using 10 and 1 ng/μL of each drug in 0.01M HC1. Stock and working solutions of methylmaprotiline (MMP, internal standard) were prepared using 1 mg/mL in methanol and 2 ng/μL in 0.01M HC1, respectively. Working solutions were distributed into small aliquots and stored for up to 3 months at -20°C until use. All other reagents were of ana lytical or HPLC grade.
Instrumentation and chromatographic conditions
Analyses were performed on a Hewlett-Packard (Meyrin, Geneva, Switzerland) HP 5890 series II GC equipped with a splitless capillary and an electronic control pressure system. The GC was linked to a quadrupole HP 5972 MS operated in the electron impact mode. The MS conditions were as follows: ion izing electron energy, 50 eV; emission current, 50 μA; ion source temperature, approximately 180°C (heated by the interface); and GC-MS capillary direct interface, 280°C. Splitless injec tions of 3 μL were made into a fused-silica Optima 5 capillary column (15 m × 0.25-mm i.d., 0.25-μm film thickness) (Macherey-Nagel, Oensingen, Switzerland) with helium as the carrier gas. The column head pressure was set to maintain a con stant flow with a pressure of 2 psi (14 KPa). The total flow was 50 mL/min and the septum purge was 3 mL/min. GC conditions were as follows: initial temperature, 160°C; initial time, 0.5 min; heating rate, 30°C/min until 260°C (final time 3.40 min); and injector temperature, 250°C. Analyses were performed in the selected-ion monitoring (SIM) mode with a dwell time of 50 ms for the ions at m/z 238 (DDCIT and DCIT), 274 (DSER and SER), 291 (MMP), 324 (CIT), and 425 (PAR).
Extraction conditions
To a 1-mL volume of heparinized plasma sample were added 100 μL of MMP (internal standard, 2 ng/μL), 1 mL of 1M sodium car bonate buffer (pH 9.4), and 6 mL of n-heptaneethylacetate (80:20, v/v). Extraction was per formed on a rotary shaker for 15 min. After centrifugation (8 min, 3400 × g), the organic layer was transferred to another tube containing 1.2 mL 0.1M HC1. After shaking for 15 min and centrifugation, the aqueous phase was transferred to another tube containing 1 mL of 1M car bonate buffer (pH 9.4) and 150 μL of toluene-isoamylalcohol (85:15, v/v). After shaking for 15 min and centrifugation for 2 min, the solvent was transferred to injection vials and evaporated to dryness under a stream of nitrogen at 40°C. 
Derivatization conditions
The residue was dissolved by thorough vortex mixing with 20 μL of N-methyl-bis(trifluoroacetamide) and left for 1 h at 60°C in a closed injec tion vial. The reagent was then evaporated to dryness under a stream of nitrogen at 40°C, reconstituted in 100 μL toluene-isoamylalcohol (85:15, v/v, thorough vortex mixing), and 3 μL was injected into the GC-MS system.
Results and Discussion
We recently described a GC-MS method for the simultaneous determination of FLV and the enantiomers of FLX and NFLX with (S)-(-)N-trifluoroacetylprolyl chloride as the derivatizing reagent (5). To our knowledge, this was the first published method which simultaneously measured the con centrations of two SSRIs. We first attempted to use the same reagent for the three remaining SSRIs without success. Apparently, there was no deriva tization under our conditions (data not shown). After several trials with other reagents, we found that a good derivatization was obtained with N-methyl-bis(trifluoroacetamide). Table I lists the main ions in the mass spectra of CIT, SER, and PAR; of their N-demethylated pharmacologically active metabolites; and of MMP after derivatization with this reagent. The probable fragmentation pathways of the molecular cations of CIT, PAR, SER, and MMP are presented in Figure 2 .
It should be mentioned that FLX, NFLX, and FLV (the other SSRIs not analyzed by the present method) are also readily derivatized with N-methyl-bis(trifluoroacetamide) and elute at retention times which are different from those of CIT, PAR, SER, and their metabolites (data not shown). We did not include FLX, NFLX, and FLV in the validation steps of the present method because we were more interested in separating the enantiomers of the former drug, which is only possible with the use of a chiral derivatizing reagent. However, the method described in the present paper could allow the simultaneous determination of the five SSRIs presently on the market; that is, if one is not interested in mea suring the enantiomers of FLX and NFLX separately. It should be mentioned that the present method and the method we previ ously described for FLX, NFLX, and FLV use the same extraction procedure. Figure 3 shows the SIM tracing of a blank plasma. Figures  4-6 are examples of chromatograms obtained from the analysis of plasma samples drawn from patients receiving 20 mg/day of CIT, 40 mg/day of PAR, and 75 mg/day of SER, respectively. The There are unequal numbers of samples included in the statistical analysis because results that were below LOQ were eliminated.
measured concentrations of CIT, DCIT, DDCIT, PAR, SER, and DSER were 43,24,16,74,29, and 56 ng/mL, respectively. Table 2 shows a summary of the statistical data on the anal ysis of CIT, PAR, SER, and their metabolites. In summary, the mean coefficients of correlation of the calibration curves obtained from four separate experiments were 0.998, 0.998, 0.991, 0.995, 0.999, and 0.995, respectively. It should be men tioned that no values are given for the intercepts because the option "force through the origin" was chosen for the calibration curves; with this option, better results were obtained for control plasma samples of low concentration (data not shown). Because pure standards of the derivatized compounds are not available, recovery was calculated by dividing the mean areas (n = 6) obtained after the complete extraction and derivatization pro cedure of plasmas containing low, medium, and high concen trations of the SSRIs by the mean areas obtained after direct derivatization of the same quantities of the pure standards.
Recoveries were satisfactory for all compounds, ranging from 81 to 118% for the tertiary amines (CIT and MMP), from 73 to 95% for the sec ondary amines (DCIT, PAR, and SER), and from 39 to 66% for the primary amines (DDCIT and DSER). The variability of the assays for the intra-(n = 8) and the interday (n = 7) experiments measured at three concen trations for each substance, as assessed by the coefficients of variation, ranged from 3 to 11% for CIT and its metabolites, from 4 to 15% for PAR, and from 5 to 13% for SER and DSER. The percent theoretical concentrations, which represent the accuracy of the method, were all within ± 10% for CIT and its metabolites, within ± 9% for PAR, and within ± 12% for SER and DSER.
The limits of quantitation are defined as the concentrations for which the mean value of replicate determinations (n = 8) is within 20% of the actual value, the coefficient of variation less than 20%, and which gives a signal-to-noise ratio of at least 10. Limits of quantitation were 2 ng/mL for CIT and PAR, 1 ng/mL for SER, and 0.5 ng/mL for DCIT, DDCIT, and DSER.
The specificity of the assay was also evaluated. Samples (200 ng) of each of the following substances diluted in methanol were dried, deriva tized, dried, reconstituted in 100 μL tolueneisoamylalcohol (85:15, v/v), and injected into the GC-MS: amitriptyline, nortriptyline, clomipra mine, desmethylclomipramine, trimipramine, desmethyltrimipramine, maprotiline, methadone, mianserin, desmethylmianserin, clozapine, desmethylclozapine, imipramine, desmethylimipramine, fluoxetine, norfluoxetine, fluvoxamine, procyclidine, risperidone, and 9-hydroxy risperi done. No interferences were noted from these 20 psychotropic drugs. Likewise, no interferences were observed from endogenous compounds fol lowing the extraction of plasma samples from six and different human controls who were not receiving any medication.
It should be noted that ions of high molecular weight or molec ular ions were intentionally chosen in order to minimize poten tial interferences from other substances. Also, MMP, which was used as the internal standard, is not a metabolite of maprotiline and is not detected in patients receiving this drug (6) . The sta bility of CIT, PAR, SER, and their metabolites was evaluated by analyzing spiked plasma samples stored at -20°C for different periods of time. No loss was noted after storage of up to 3 months. Finally, the stability of the derivatized forms of these three SSRIs with their metabolites was evaluated. No change was noted after storage of up to 3 days at room temperature (data not shown).
Before the development of the present method, the concentra tions of CIT, DCIT, and DDCIT were measured in our laboratory using GC with a nitrogen-phosphorus detector (GC-NPD) after derivatization of the secondary and primary amines with trifluoroacetic anhydride (7) . Sixty plasma samples which were sent to our laboratory for therapeutic drug monitoring of CIT using GC-NPD were reanalyzed using GC-MS. Table 3 shows the good correlations obtained between the two methods. It should be men tioned, however, that one value of DCIT was excluded from the sta tistical analysis because of a marked difference in the results between the two methods (142 ng/mL with GC-NPD and 30 ng/mL with GC-MS). We believe that the high DCIT concentration in the former method was caused by an unknown substance, probably a comedication, eluting at the same retention time.
Conclusion
This method, which is both sensitive and selective, allows the simultaneous quantification of CIT, PAR, SER, and their N-demethylated metabolites in plasma samples and can be used for single-dose pharmacokinetic studies. This procedure decreases the cost and time of analysis. It provides a good alter native analytical method for psychiatric patients who are often comedicated and also for patients who are medicated with two SSRIs (4). Finally, this method could probably be used for the simultaneous quantification of the five SSRIs on the market.
